Biotech News
MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)
investors.mannkindcorp.com2026-05-06 14:54 EST
Study to assess safety, efficacy and treatment experience of starting inhaled insulin in youth aged 10 to